State Of Wyoming Chemo Centryx, Inc. Transaction History

State Of Wyoming

$676 Million
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $6,328 - $11,334	-412 Reduced 28.91%	1,013 $25,000
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $31,307 - $55,120	1,409 Added 8806.25%	1,425 $36,000
Q4 2021 Feb 11, 2022	SELL	$18.38 - $40.5 $735 - $1,620	-40 Reduced 71.43%	16 $1,000
Q2 2021 Feb 11, 2022	BUY	$9.59 - $50.88 $287 - $1,526	30 Added 115.38%	56 $1,000
Q1 2021 Feb 08, 2022	BUY	$49.53 - $68.4 $1,287 - $1,778	26 New	26 $1,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.